Showing results (181-190 of 203) with videos related to
Sort By:
Pageof 21
Emerging Infectious Diseases|February 2, 2010
Novel human bocavirus in children with acute respiratory tract infectionJing-rong Song, Yu Jin, Zhi-ping Xie, et al.Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decadesCheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, et al.BMC Medical Genomics|July 15, 2025
Genetic etiology of 283 Chinese individuals with epilepsy using copy number variation sequencing and whole exome sequencing: a single-center cohort studyJunji Hu, Min Xin, Jinxiu Liu, et al.Zeitschrift Fur Naturforschung. C, Journal of Biosciences|February 19, 2013
Isolation and characterization of an endosperm-specific promoter from wheat (Triticum aestivum L.)Fei Song, Cui-Ju Cui, Ling Chen, et al.Journal of Medical Virology|January 9, 2013
Prevalence of human metapneumovirus in children with acute lower respiratory infection in Changsha, ChinaNi-guang Xiao, Bing Zhang, Zhi-ping Xie, et al.Journal of Cancer|January 3, 2022
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapiesYu-Chuan Yan, Guang-Xiao Meng, Zi-Niu Ding, et al.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|July 28, 2011
[Detection and clinical study on coronavirus HKU1 with acute lower respiratory tract infections of hospitalized children in Changsha]Ni-guang Xiao, Zhi-ping Xie, Qiong-hua Zhou, et al.Frontiers in Immunology|February 25, 2022
The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-AnalysisCheng-Long Han, Guang-Xiao Meng, Zi-Niu Ding, et al.Cell Death Discovery|March 7, 2025
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolismChun-Cheng Yang, Yu-Chuan Yan, Guo-Qiang Pan, et al.Expert Review of Gastroenterology & Hepatology|December 8, 2022
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysisBao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, et al.Pageof 21